Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Meningiomas are common primary brain tumors in dogs; however, little is known about the molecular genetic mechanisms involved in their tumorigenesis. Several tumor suppressor genes have been implicated in meningioma pathogenesis in humans, including the neurofibromatosis 2 (NF2), protein 4.1B (4.1 B), and tumor suppressor in lung cancer-1 (TSLC1) genes. We investigated the expression of these tumor suppressor genes in a series of spontaneous canine meningiomas using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) (NF2; n = 25) and western blotting (NF2/merlin, 4.1B, TSLC1; n = 30). Decreased expression of 4.1B and TSLC1 expression on western blotting was seen in 6/30 (20%) and in 15/30 (50%) tumors, respectively, with 18/30 (60%) of meningiomas having decreased or absent expression of one or both proteins. NF2 gene expression assessed by western blotting and RT-PCR varied considerably between individual tumors. Complete loss of NF2 protein on western blotting was not seen, unlike 4.1B and TSLC1. Incidence of TSLC1 abnormalities was similar to that seen in human meningiomas, while perturbation of NF2 and 4.1B appeared to be less common than reported for human tumors. No association was observed between tumor grade, subtype, or location and tumor suppressor gene expression based on western blot or RT-PCR. These results suggest that loss of these tumor suppressor genes is a frequent occurrence in canine meningiomas and may be an early event in tumorigenesis in some cases. In addition, it is likely that other, as yet unidentified, genes play an important role in canine meningioma formation and growth.
Dickinson
P J
PJ
Department of Surgical and Radiological Sciences, Tupper Hall, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA. pjdickinson@ucdavis.edu
Surace
E I
EI
Cambell
M
M
Higgins
R J
RJ
Leutenegger
C M
CM
Bollen
A W
AW
LeCouteur
R A
RA
Gutmann
D H
DH
D000818:Animals; D015153:Blotting, Western / Q000662:veterinary; D004283:Dog Diseases / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D004285:Dogs; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology*; D008577:Meningeal Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000662:veterinary*; D008579:Meningioma / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000662:veterinary*; D016518:Neurofibromatosis 2 / Q000235:genetics / Q000378:metabolism*; D025581:Neurofibromin 2 / Q000235:genetics / Q000378:metabolism*; D012334:RNA, Neoplasm / Q000737:chemistry / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
D025581:Neurofibromin 2; D012334:RNA, Neoplasm; D025521:Tumor Suppressor Proteins